Net Sales Margin: Avid Bioservices Inc (CDMO)

Official company branding of Avid Bioservices, Inc (CDMO)

The impeccable image of Avid Bioservices, Inc. (CDMO) among industry giants is confirmed by the net profit margin on the GURU.Markets chart, where -101.10 captures the current state of the parameter. Stable cash flows driven by long-term contracts and the operation of proprietary cGMP facilities in California determine the current price action. These factors ensure operational resilience and technological control over the production of biologics.

CDMO: Avid Bioservices Inc Net Profit Rate 07/04/2022 - 02/16/2025

Summary analytical data breakdowns for Avid Bioservices Inc (CDMO)

- share price and expert price forecast:
- company stock exchange capitalization indicators:
Comprehensive company analysis:Avid Bioservices, Inc.
Flagship merchandise of Avid Bioservices, Inc

Identifying fundamentally resilient assets requires a rigorous analysis of how effectively revenue converts into net income. This indicator measures the portion of profit remaining after all expenses per unit of sales. For Avid Bioservices, Inc. (CDMO), this reflects the profitability of developing and producing biologics for pharma behemoths. The company's net profit margin trend on GURU.Markets captures the real inflow of liquidity. By analyzing this chart, an investor assesses the business model's resilience to operating expenses.